Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?
DOI:
https://doi.org/10.6061/clinics/2019/e1517Downloads
Download data is not yet available.
Published
2019-10-09
Issue
Section
Comments
How to Cite
Gomes, L. E. M., Silva, F. A. R. da, Pascoal, L. B., Ricci, R. L., Nogueira, G., Camargo, M. G., Ayrizono, M. de L. S., Fagundes, J. J., & Leal, R. F. (2019). Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn’s disease: what are the reasons for differences from previous studies?. Clinics, 74, e1517. https://doi.org/10.6061/clinics/2019/e1517